|
Dec 5
|
UPDATE 1-Johnson & Johnson forecasts as much as 6% sales growth in 2024
|
|
Dec 5
|
Johnson & Johnson Stock Edges Higher After Guidance Release
|
|
Dec 5
|
Johnson & Johnson Targets Sales Growth in Years Ahead
|
|
Dec 5
|
J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag
|
|
Dec 5
|
Midday movers: CVS Health, Apple, and more
|
|
Dec 5
|
Johnson & Johnson forecasts as much as 6% sales growth in 2024
|
|
Dec 5
|
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
|
|
Dec 5
|
J&J pitches investors on sales growth from cancer, immune disease drugs
|
|
Dec 4
|
The past one-year earnings decline for Johnson & Johnson (NYSE:JNJ) likely explains shareholders long-term losses
|
|
Dec 4
|
The Executives Who Could Be Johnson & Johnson’s Next CEO
|
|
Dec 3
|
Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock
|
|
Dec 3
|
Warren Buffett sold a whopping $7B worth of stock in Q3 — and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong
|
|
Dec 3
|
Warren Buffett Just Closed His Position in This Dividend Giant. Should You?
|
|
Dec 2
|
JP Morgan’s Top 15 Stock Picks for 2023 and Now
|
|
Dec 1
|
Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day
|
|
Dec 1
|
Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls
|
|
Nov 30
|
UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims
|
|
Nov 30
|
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
|
|
Nov 30
|
Johnson & Johnson MedTech Acquires Laminar, Inc.
|
|
Nov 30
|
J&J heats up LAA closure competition with $400M Laminar buy
|